All In Biotech

Drug Trial Radar · NCT00002160

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

100

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
NeurexIndustry
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.

Conditions

  • HIV Infections
  • Cancer
  • Pain

Interventions

  • ZiconotideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Ctr for Pain Management and Rehabilitation

    Huntsville, Alabama

  • Gulf Coast Clinical Services

    Mobile, Alabama

  • Northport Hosp

    Northport, Alabama

  • Holt Krock Clinic

    Fort Smith, Arkansas

  • Alta Bates Hosp

    Berkeley, California

  • Pain Diagnosis and Treatment

    Glendora, California

  • Univ of CA - San Diego

    San Diego, California

  • Good Samaritan Hosp Ctr

    San Jose, California

  • Connecticut Pain Care

    Danbury, Connecticut

  • VA Med Ctr / Oncology Section

    Washington D.C., District of Columbia

  • Univ of Miami School of Medicine

    Miami, Florida

  • H Lee Moffit Cancer Ctr and Research Institute

    Tampa, Florida

  • Emory Univ Hosp

    Atlanta, Georgia

  • Cook County Hosp

    Chicago, Illinois

  • Pain Control Ctr

    Chicago, Illinois

  • Elkhardt Gen Hosp

    Elkhardt, Indiana

  • Neurosurgical Associates

    Terre Haute, Indiana

  • Univ of Iowa Hosp

    Iowa City, Iowa

  • Univ of Kansas Med Ctr

    Kansas City, Kansas

  • New Orleans Pharmaceutical Research

    Kenner, Louisiana

  • Louisiana State Univ

    Shreveport, Louisiana

  • Johns Hopkins Hosp

    Baltimore, Maryland

  • Brigham and Women's Hosp

    Boston, Massachusetts

  • Minneapolis Veterans Administration

    Minneapolis, Minnesota

  • Univ of Missouri Med Ctr

    Columbia, Missouri

  • The Pain Institute

    Kansas City, Missouri

  • Cooper Hospital Early Intervention Program

    Camden, New Jersey

  • Clinical Solutions

    Princeton, New Jersey

  • Pain Management

    New York, New York

  • Long Island Pain Management

    Port Jefferson Station, New York

  • Univ of Rochester

    Rochester, New York

  • Bowman Gray School of Medicine / Wake Forest Univ

    Winston-Salem, North Carolina

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • Lehigh Valley Hosp

    Allentown, Pennsylvania

  • Pennsylvania State College of Medicine

    Hershey, Pennsylvania

  • Thomas Jefferson Univ Hosp

    Philadelphia, Pennsylvania

  • Methodist Hosp

    Memphis, Tennessee

  • Univ of Tennessee

    Memphis, Tennessee

  • Texas Tech Univ Health Science Ctr

    Lubbock, Texas

  • Univ of Texas Health Sciences Ctr

    San Antonio, Texas

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.